RRML - Thrombophilia genetic testing in Romanian young women with acute thrombotic events: role of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and A1298C polymorphisms
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2016): 55%

Română English


SCImago Journal & Country Rank


Advanced search


Top 10 downloaded articles
- February 2018 -
 
Innate Immune Mechanisms in Myoca... 19
Diagnostic accuracy of red blood ... 18
Ischemic modified albumin increas... 17
Spontaneous atrial fibrillation a... 17
Plasma phosphorylated neurofilame... 14
The impact of immunological and b... 12
Associations of pathogenic mutati... 11
CXCL13 levels are more increased ... 10
The frequency of Human Papillomav... 10
Thrombophilia genetic testing in ... 9

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 24(3)/2016 DOI:10.1515/rrlm-2016-0032
XML
TXT

Research article

Thrombophilia genetic testing in Romanian young women with acute thrombotic events: role of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and A1298C polymorphisms

Evaluarea genetică a trombofiliilor la femei tinere din România cu evenimente acute trombotice: rolul Factorului V Leiden, Protrombinei G20210A, polimorfismelor MTHFR C677T și A1298C

Ana Maria Daraban, Adrian Pavel Trifa, Radu Anghel Popp, Diana Botezatu, Marinela Șerban, Valentina Uscatescu, Rodica Talmaci, Daniel Coriu, Carmen Ginghina, Ruxandra Oana Jurcut

Correspondence should be addressed to: Ruxandra Oana Jurcut

Abstract

Objective: The present case-control study aimed at evaluating the contribution of thrombophilic polymorphisms to acute venous (VTE) as well as arterial thrombotic events (ATE) in a population of young women with few traditional thrombotic factors (CVRF). Methods: We consecutively enrolled patients under 45 years of age, with less than 3 CVRF, evaluated for VTE or ATE, women and men as a comparator. The control group consisted of healthy young women. A thrombophilia panel and genetic testing for Factor V Leiden (FVL), G20210A Prothrombin and MTHFR polimorphisms were done. Results: A total of 323 persons were enrolled: 71 women and 121 men with thromboembolic events, and 131 healthy female as controls. Hyperhomocysteinemia was more frequent in ATE (30.4%) than VTE female patients (6.25%), p<0.01. Genetic testing was available in 45 women and 84 men with acute thrombotic events and in all controls. Homozygous FVL was associated with VTE in young women (10.3% vs 0% controls, p<0.01). Prothrombin G20210A polymorphism had the lowest prevalence - 5.4% and only heterozygosity was found. MTHFR C677T heterozygosity showed no significant difference between women patients and controls (62.2 % vs 43.5% respectively, p=0.1). The homozygous status, less frequent (6.6%), was not associated with ATE or VTE. Homozygous MTHFR A1298C was associated with VTE in women (17.2% patients vs 4.5% controls, OR 4.34, p 0.02, CI 1.22-15.3). Conclusion: In young women with few CVRF, mild hyperhomocysteinemia, homozygosity for FVL and for MTHFR A1298C polymorphisms increase the risk for VTE but not ATE. MTHFR polymorphisms are found with increased frequency in both healthy persons and patients therefore, their significance as an important thrombotic risk modifier remains unclear.

Keywords: Thrombophilia;Factor V Leiden;Prothrombin G20210A;MTHFR C677T and A1298C

Received: 13.6.2016
Accepted: 5.9.2016
Published: 12.9.2016

 
  PDF Download full text PDF
(417 KB)
     
 
How to cite
Daraban AM, Trifa AP, Popp RA, Botezatu D, Șerban M, Uscatescu V, et al. Thrombophilia genetic testing in Romanian young women with acute thrombotic events: role of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and A1298C polymorphisms. Rev Romana Med Lab. 2016;24(3):291-305. DOI:10.1515/rrlm-2016-0032